HCW Biologics Inc. (HCWB)
0.7352
-0.03
(-3.76%)
USD |
NASDAQ |
Nov 19, 10:58
HCW Biologics Total Assets (Quarterly) : 25.13M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 25.13M |
| June 30, 2026 | 26.77M |
| March 31, 2026 | 27.34M |
| December 31, 2025 | 24.52M |
| September 30, 2025 | 25.45M |
| June 30, 2025 | 28.91M |
| March 31, 2025 | 26.29M |
| December 31, 2024 | 30.24M |
| September 30, 2024 | 26.56M |
| June 30, 2024 | 26.82M |
| March 31, 2024 | 30.43M |
| December 31, 2023 | 28.51M |
| Date | Value |
|---|---|
| September 30, 2023 | 35.62M |
| June 30, 2023 | 39.48M |
| March 31, 2023 | 43.53M |
| December 31, 2022 | 46.81M |
| September 30, 2022 | 51.35M |
| June 30, 2022 | 47.41M |
| March 31, 2022 | 50.96M |
| December 31, 2021 | 53.51M |
| September 30, 2021 | 56.41M |
| June 30, 2021 | 13.03M |
| March 31, 2021 | 12.93M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | 5.832M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.166B |
| Anixa Biosciences, Inc. | 15.07M |
| Vicapsys Life Sciences, Inc. | 0.1325M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.30M |
| Shareholders Equity (Quarterly) | 6.823M |
| Debt to Equity Ratio | 1.001 |
| Current Ratio | 0.0727 |
| Net Debt Paydown Yield | 8.92% |